.Pharmacolibrary.Drugs.ATC.A.A10AB06

Information

name:InsulinGlulisine
ATC code:A10AB06
route:subcutaneous
n-compartments1

Insulin glulisine is a rapid-acting insulin analogue used in the management of diabetes mellitus for the control of blood glucose. It is administered to mimic the prandial (meal-time) insulin peak and is approved for use in both type 1 and type 2 diabetes. Currently, it is an approved and commonly used medication for insulin therapy.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult volunteers following subcutaneous administration.

References

  1. Chao, M, et al., & Ning, G (2010). Bioequivalence between two human insulin analogs in Chinese population: Glulisine and Lispro. Endocrine 38(1) 48–52. DOI:10.1007/s12020-010-9326-4 PUBMED:https://pubmed.ncbi.nlm.nih.gov/20960101

  2. Danne, T, et al., & Rave, K (2005). Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes. Diabetes care 28(9) 2100–2105. DOI:10.2337/diacare.28.9.2100 PUBMED:https://pubmed.ncbi.nlm.nih.gov/16123473

Revisions

Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos